3rslkEbYP

Uso medicinal da maconha e outras drogas atualmente ilícitas 219CARNEIRO, H. Autonomia ou heteronomia nos estados alterados de consciência. In: LABA-TE, B., GOULART, S., FIORE, M., MACRAE, E., CARNEIRO, H. (Orgs.). Drogas eCultura: novas perspectivas. Salvador-BA: EDUFBA, v. , p. 65-90, 2008.DEGENHARDT, L, CHIU, W, SAMPSON, N, KESSLER, RC, ANTHONY, JC, ANGER-MEYER, M, BRUFFAERTS, R, GIROLANO, G de, GUREJE, O, HUANG, Y, KARAM,A, KOSTYUCHENKO, S, LEPINE, JP, MORA, MEM, NEUMARK, Y, ORMEL, J,PINTO-MEZA, A, POSADA-VILLA, J, STEIN, DJ, TAKESHIMA, T, WELLS, JE. Towarda global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the who WorldMental Health Surveys. PLoSMed 5(7):e141. doi: 10.1371, 2008.DEL, Cul A, DEHAENE, S, REYES, P, BRAVO, E, SLACHEVSKY, A. Causal role of prefrontalcortex in the threshold for access to consciousness. Brain, 2009 - Oxford University Press, 2009.D’SOUZA, DC, RANGANATHAN, M, BRALEY, G, GUEROGUIEVA, R, ZIMOLO, Z,COOPER, T, PERRY, E, KRYSTAL, J. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 33:2505–16, 2008.DOBLIN, R. A clinical plan for MDMA (Ecstasy) in the treatment of post-traumatic stress disorder(PTSD): Partnering with the FDA. J Psychoactive Drugs 34(2): 185–194, 2002.DUMONT, GJ, SWEEP, FC, STEEN, R van der, HERMSEN, R, DONDERS, AR, TOUW,DJ et. al. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy(3,4-methylenedioxymethamphetamine) administration. SocNeurosci 4: 359-366, 2009.Editorial Brewing a pot of hysteria. Nature Neuroscience 8, 971. doi:10.1038/nn0805-971,2005.ESCOHOTADO, A. História elementar das drogas. J.C. Barreiros (trad.). Antígona, 1 a ed., 2004.Expertise Pesquisas (2014). Pesquisa Maconha. URL: .Acesso em 21 fev 2014.Gallup (2013).GASSER, P., HOLSTEIN, D., MICHEL, Y., DOBLIN, R., YAZAR-KLOSINSKI, B.,PASSIE, T., BRENNEISEN, R. Safety and effi cacy of lysergic acid diethylamide-assisted psychotherapyfor anxiety associated with life-threatening diseases. The Journal of Nervous and MentalDisease (Epub). doi:10.1097/NMD.0000000000000113.GRANT, I., ATKINSON, J.H., GOUAUX, B., WILSEY, B. Medical cannabis: Clearing awaythe smoke. The Open Neurology Journal 6: 18-25, 2012.GREER, G., TOLBERT, R. The therapeutic use of MDMA, pp. 21-36. In: Ecstasy: The Clinical,Pharmacological, and Neurotoxicological Effects of the Drug MDMA, Peroutka, SJ(ed.) Springer, 1989.GROB, C. S., DANFORTH, A. L., CHOPRA, G. S., HAGERTY, M., MCKAY, C. R., HAL-BERSTADT, A. L., GREER, G. R. Pilot study of psilocybin treatment for anxiety in patientswith advanced-stage cancer. Archives of General Psychiatry, 68(1), 71–8, 2011.GUINDON, J., HOHMANN, A. G. The endocannabinoid system and cancer: therapeutic implication.Br J Pharmacol 163(7): 1447-63, 2011.HAGENBACH, D., WERTHMÜLLER, L. Mystic Chemist: The Life of Albert Hofmann andHis Discovery of LSD. Santa Fe, Ne: Synergetic Press, 2013.